ENTEROBIOTIX LIMITEDActive

Company number SC559230Private limited companyIncorporated 2017

Key figures

£9,383,894+49.1%
Net assets 2021/22
+6.3%
Average annual growth 2019/20–2021/22
02.5 m5 m7.5 m10 m2019/202020/212021/22

Like most small UK companies, ENTEROBIOTIX LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2021/22
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
05 m10 m2019/202020/212021/22
Filed accounts2019/20–2021/22
2019/202020/212021/22
Cash at bank and in hand7,991,1065,501,9655,272,264
Total assets8,323,5716,439,2236,579,548
Total liabilities129,126538,343599,511
Net assets / total equity8,296,8626,291,8129,383,894
Average number of employees111828

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: ENTEROBIOTIX LIMITED

Company

ENTEROBIOTIX LIMITED is a private limited company registered with Companies House under company number SC559230. It was incorporated on 2 Mar 2017. Its status is active. The registered office is in Bellshill (ML4). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).

Accounts

The latest accounts in the database are for 2021/22 (period ending 31 Mar 2022); the company files full accounts. Net assets were £9,383,894, up 49.1% on the previous year. Cash at bank and in hand was £5,272,264. Total assets were £6,579,548 and total liabilities £599,511. The company had an average of 28 employees. Figures are available for 3 financial years (2019/20–2021/22).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 3 May 2027.